United Health Products Inc.

11/17/2026 | Press release | Distributed by Public on 11/17/2026 14:45

Late Filing Notice (Form NT 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one):

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

For Period Ended: September 30, 2026

☐

Transition Report on Form 10-K

☐

Transition Report on Form 20-F

☐

Transition Report on Form 11-K

☐

Transition Report on Form 10-Q

☐

Transition Report on Form N-SAR

For the Transition Period Ended: ________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

United Health Products, Inc.

Full Name of Registrant

Former Name if Applicable

320 Boston Post Road, Suite 180

Address of Principal Executive Office (Street and Number)

Darien, CT 06820

City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

☒

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

(c)

The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report portion thereof, could not be filed within the prescribed time period.

(Attach extra Sheets if Needed)

The Registrant was unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 within the prescribed time period without unreasonable effort or expense due to a widespread service disruption affecting Microsoft cloud services beginning on November 12, 2026. The disruption impaired the Registrant's access to its document management and collaboration platforms on MS SharePoint and to emails servers used in the Registrant's quarterly books close and disclosure review process, and interrupted the exchange of draft financial statements and supporting documentation with the Registrant's independent registered public accounting firm, which impacted the Registrant's ability to complete and review its interim financial statements prior to the due date as a result. The Registrant is geographically remote from its independent registered public accounting firm's location and the Registrant did not have an alternative to complete its Quarterly Report on Form 10-Q and get the information to them securely without unreasonable effort or expense; particularly not knowing how long the disruption would persist. The Registrant currently anticipates filing the Quarterly Report within the five-calendar-day extension period provided by Rule 12b-25.

PART IV - OTHER INFORMATION

(1)

Name and telephone number of person to contact in regard to this notification

Brian Thom

(475)

755-1005

(Name)

(Area Code)

(Telephone Number)

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Registrant Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

Yes ☒ No ☐

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes ☐ No ☒

United Health Products, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 17, 2026

By:

/s/ Brian Thom

Brian Thom

Chief Executive Officer

United Health Products Inc. published this content on November 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 17, 2026 at 20:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]